Clinical trial

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients…

NCT00002546 · Gynecologic Oncology Group, Other · Completed

Key facts

NCT number NCT00002546
Title Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Official title A Phase III Randomized Study of Accelerated Hyperfractionated Whole Abdominal Radiotherapy (AHWAR) Versus Combination Ifosfamide-Mesna With Cisplatin in Optimally Debulked Stage I, II, III, or IV Carcinosarcoma (CS) of The Uterus
Lead sponsor Gynecologic Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Sarcoma
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, ifosfamide, adjuvant therapy, radiation therapy
Enrollment 216
Start date Dec 1, 1993
Primary completion Sep 1, 2007
First posted Jan 27, 2003
Last update posted Feb 11, 2016
Countries South Africa, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies